Fabris B - Search Results

1

TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases.

Bernardi S, Milani D, Fabris B, Secchiero P, Zauli G. Bernardi S, et al. Among authors: fabris b. Curr Drug Targets. 2012 Aug;13(9):1215-21. doi: 10.2174/138945012802002357. Curr Drug Targets. 2012. PMID: 22676911 Review.

2

TRAIL modulates the immune system and protects against the development of diabetes.

Bossi F, Bernardi S, Zauli G, Secchiero P, Fabris B. Bossi F, et al. Among authors: fabris b. J Immunol Res. 2015;2015:680749. doi: 10.1155/2015/680749. Epub 2015 Feb 18. J Immunol Res. 2015. PMID: 25759846 Free PMC article. Review.

3

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease.

Bernardi S, Bossi F, Toffoli B, Fabris B. Bernardi S, et al. Among authors: fabris b. Biomed Res Int. 2016;2016:1752854. doi: 10.1155/2016/1752854. Epub 2016 Apr 21. Biomed Res Int. 2016. PMID: 27200369 Free PMC article. Review.

4

Association between thyroid hormones and TRAIL.

Bernardi S, Bossi F, Toffoli B, Giudici F, Bramante A, Furlanis G, Stenner E, Secchiero P, Zauli G, Carretta R, Fabris B. Bernardi S, et al. Among authors: fabris b. Clin Biochem. 2017 Nov;50(16-17):972-976. doi: 10.1016/j.clinbiochem.2017.05.011. Epub 2017 May 25. Clin Biochem. 2017. PMID: 28551332 Free article.

5

TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.

Bernardi S, Toffoli B, Tisato V, Bossi F, Biffi S, Lorenzon A, Zauli G, Secchiero P, Fabris B. Bernardi S, et al. Among authors: fabris b. Clin Sci (Lond). 2018 Jan 5;132(1):69-83. doi: 10.1042/CS20171221. Print 2018 Jan 16. Clin Sci (Lond). 2018. PMID: 29167318 Free article.

6

TRAIL treatment prevents renal morphological changes and TGF-β-induced mesenchymal transition associated with diabetic nephropathy.

Toffoli B, Tonon F, Tisato V, Michelli A, Zauli G, Secchiero P, Fabris B, Bernardi S. Toffoli B, et al. Among authors: fabris b. Clin Sci (Lond). 2020 Sep 18;134(17):2337-2352. doi: 10.1042/CS20201004. Clin Sci (Lond). 2020. PMID: 32857135 Free article.

7

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake.

Toffoli B, Tonon F, Tisato V, Zauli G, Secchiero P, Fabris B, Bernardi S. Toffoli B, et al. Among authors: fabris b. Cell Death Dis. 2021 Nov 16;12(12):1089. doi: 10.1038/s41419-021-04383-3. Cell Death Dis. 2021. PMID: 34789726 Free PMC article.

8

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes.

Zauli G, Toffoli B, di Iasio MG, Celeghini C, Fabris B, Secchiero P. Zauli G, et al. Among authors: fabris b. Diabetes. 2010 May;59(5):1261-5. doi: 10.2337/db09-1771. Epub 2010 Feb 25. Diabetes. 2010. PMID: 20185810 Free PMC article.

9

TRAIL shows potential cardioprotective activity.

Toffoli B, Bernardi S, Candido R, Zacchigna S, Fabris B, Secchiero P. Toffoli B, et al. Among authors: fabris b. Invest New Drugs. 2012 Jun;30(3):1257-60. doi: 10.1007/s10637-010-9627-8. Epub 2011 Jan 4. Invest New Drugs. 2012. PMID: 21197620

10

Bernardi S, Zauli G, Tikellis C, Candido R, Fabris B, Secchiero P, Cooper ME, Thomas MC. Bernardi S, et al. Among authors: fabris b. Clin Sci (Lond). 2012 Nov;123(9):547-55. doi: 10.1042/CS20120176. Clin Sci (Lond). 2012. PMID: 22616837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters